Delivery Order SPE2DB22D1017-SPE2DB25FE7PW
Award Date
10/21/24
Potential Completion Date
11/12/24
Potential Value
$8.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,157.40 firm-fixed-price delivery order contract is for the supply of Venclexta 100 mg tablets, a medication used in the treatment of certain types of blood cancers. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 firm-fixed-price delivery order contract is for the supply of Venclexta 100 mg tablets, a specialty medication used to treat certain types of cancer. The contract has an ultimate completion date of November 19, 2024. This award is associated with a broader Indefinite Delivery Contract (IDC) between...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,554.12 firm fixed price delivery order is for the supply of 4,561,823,045 units of the 100 mg tablet form of the cancer medication Venclexta. The contract has a completion date of September 6, 2023 and was awarded on August 15, 2023. This delivery order is part of a larger $999,999,999 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,187.06 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets, a specialty medication used in the treatment of certain types of cancer. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,187.06 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets, a specialty medication used in the treatment of certain blood cancers. The award is associated with AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $17,760.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Venclexta 100 mg tablets, a medication used in the treatment of certain types of cancer. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,880.15 firm fixed-price delivery order is for the supply of Venclexta 100 mg tablets. The contract has an ultimate completion date of April 29, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $8,880.15 firm fixed-price delivery order is for the supply of VENCLEXTA 100 MG TABLET, a specialty cancer medication. The contract has an ultimate completion date of August 14, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999 through December 2025 for delivering a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,728.17 Firm Fixed Price Delivery Order contract is for the supply of VENCLEXTA 100 MG TABLET, a medication used in the treatment of certain types of blood cancer. This contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award, valued at $8,880.15, was issued by the Defense Logistics Agency (DLA) to the pharmaceutical distributor AmerisourceBergen Drug Corp. The contract is a delivery order for the supply of the medication Venclexta 100 mg tablets, with an ultimate completion date of November 14, 2024. The contract is not designated as a set-aside and was awarded on a firm-fixed price basis. AmerisourceBergen, a major healthcare solutions provider, maintains an Indefinite Delivery...